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Public Health and Meaningful Use in 2017:  
Guidance for Public Health Agencies 
08/18/2016 
Providers have the option of attesting to the Stage 3 measures in 2017. The EHR reporting period for providers 
attesting to Stage 3 in 2017 will be 90 days, whereas providers who choose to attest to Modified Stage 2 in 2017 
will have a full calendar year EHR reporting period. A new requirement for Public Health Agencies (PHAs) for Stage 
3 is to declare readiness to accept data consistent with Stage 3 measures and 2015 Edition CEHRT criteria at least 
six months in advance of the provider’s EHR reporting period. For example, if a PHA plans to accept Stage 3 
criteria on or before January 1, 2017, they should declare readiness on their publicly available website by July 1, 
2016.   
Declaration of Readiness 
 The PHA should include a statement declaring its readiness on its publicly-available website 
 Six months in advance of when the PHA plans to accept (e.g. by July 1, 2016 to capture provider EHR 
reporting periods beginning January 1, 2017) 
 Declaration should include: 
o Which measures will be supported 
o Which CEHRT edition(s) (2014 and/or 2015) are supported or specific implementation guides and 
requirements from the ONC rule(s) 
o Any EH/CAH/EP restrictions or targets based on factors such as provider type 
o Date PHA will begin accepting data consistent with the new criteria 
 Keep track of changes to the declaration of readiness for each measure. Maintaining a history of any date 
of declaration (e.g. posting on the webpage) and the standards supported on the web page can provide 
documentation to a provider in the event they are audited.  Consider having this history information 
available on the PHA MU website. 
 
General Considerations for 2017 
 PHAs may need to be able to accept both 2014 Edition and 2015 Edition CEHRT standards simultaneously. 
 Providers will be transitioning to 2015 Edition software and may use a combination of 2014 and 2015 
Edition software, regardless of the Stage to which they are attesting. 
 As EHR vendors update their software to 2015 Edition criteria, there may be significant changes that 
would require revalidation by the PHA for providers in production status. 
Immunization Registry 
 Readiness for Stage 3 includes: 
o The ability to respond to bidirectional queries (QBP/RSP). 
o The capacity to receive NDC codes (Note: an IIS may also opt to require CVX codes in parallel with 
NDC codes until full adoption of NDC codes has been completed). 
 Declarations of readiness for Stage 3 MU, bidirectional queries, and NDC codes should be in addition to, 
rather than replace existing readiness declarations for Stage 2 MU (unidirectional reporting). 
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Syndromic Surveillance 
 In Stage 3, syndromic surveillance for EPs is limited to those in an urgent care setting.  
o If the PHA plans to accept syndromic surveillance from EPs in other settings, the PHA should 
consider declaring this acceptance under the Public Health Registry Reporting Measure (formerly 
Specialized Registry Reporting).   
 The PHIN messaging guide for hospital syndromic surveillance is upgraded to version 2.0 in the 2015 
Edition CEHRT (Note: the rule does not specify a guide for syndromic surveillance in regards to ambulatory 
care, but notes the PHIN 2.0 guide is appropriate for use in urgent care ambulatory settings).  Important 
changes include: 
o PHAs operating syndromic surveillance systems (SyS) will need to adjust SyS message receiving 
and data transformation processes.  
o Under 2015 Edition SyS should also provide additional facility and patient demographic 
information, including: 
 Facility name 
 Facility address 
 Patient city, state, country 
 Patient class 
 Height and weight  
 Smoking status 
o Certification testing of SyS messaging was expanded to include the capture and transmission of 
ICD-9 CM, ICD-10 CM, LOINC, and SNOMED coded data along with Chief Complaint; under 2014 
Edition CEHRT, testing for compliance was limited to ICD-9 CM and Chief Complaint.  
 
 The PHIN 2.0 guide is to be used for emergency department, urgent care and inpatient settings. While EHs 
without emergency departments can claim an exclusion for SyS, the new guide allows for the transmission 
of inpatient data. The PHA should determine if inpatient visits will be requested in addition to emergency 
department or urgent care visits.  
 
Cancer Registry (under Public Health Registries)  
 The Cancer Implementation Guide for ambulatory provider cancer reporting to state cancer registries is 
updated to HL7 CDA ® Release 2 Implementation Guide: Reporting to Public Health Cancer Registries from 
Ambulatory Healthcare Providers, Release 1, DSTU Release 1.1 – US Realm in the 2015 Edition CEHRT. 
Important changes include: 
o Addition of “Modification to the cancer patient’s EHR” as a second criterion (trigger) for 
identifying cancer cases 
o Addition of SNOMED cancer reportability list  
o Alignment with Consolidated CDA (C-CDA)  
o New sections, entries and data elements, including: 
 Document versioning elements 
 Use of identifiers within the document to link cancer diagnosis, problems and medications 
to the related problem 
 TNM Pathologic Stage 
 Tumor grade 
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 Smoking and tobacco use 
 Family medical history 
o Changes to optionality, mostly to strengthen the requirements for some key cancer data 
elements. 
Public Health Registries  
 Starting in Stage 3, all Public Health Registries and Clinical Data Registries must use certified standards for 
meaningful use transactions. In 2017, providers can use a combination of 2014 Edition and 2015 Edition 
CEHRT. This is in contrast to Modified Stage 2 where use of ONC standards are not required if they are not 
present in the 2014 Edition CEHRT. 
 The Centers for Disease Control and Prevention offers two registries (one available starting 2018): 
o National Center for Health Statistics – national health care surveys, which is currently accepting 
registrations from eligible hospitals, critical access hospitals and eligible professionals. A PHA may 
post information regarding this option on their MU webpage. 
o National Healthcare Safety Network – antimicrobial use and resistance reporting (EH and CAH 
only), which plans to start accepting in 2018. 
Electronic Reportable Lab Results  
 There are no changes to the HL7 implementation guide used for Electronic Laboratory Reporting. 
 Despite no changes, there may be a need to revalidate if a hospital updates or purchases new certified 
software. 
Electronic Case Reporting 
 Not available for Stage 3 until 2018, however a PHA may elect to have Case Reporting as a Public Health 
Registry or Specialized Registry prior to 2018. 
 
 
 
 
Compiled by the Stage 3 Meaningful Use Public Health Reporting Requirements Task Force.  
For this and other Task Force documents, please visit cdc.gov/ehrmeaningfuluse/meaningful-use-mu-public-
health-ph-reporting-requirements-task-force.html. 
If you have questions, please contact meaningfuluse@cdc.gov, or visit the EHR Meaningful Use website at 
cdc.gov/ehrmeaningfuluse. 
Information for this document has been abstracted from the CMS and ONC regulations and represents the public 
health measures only. For the full and final guidance, please refer to the ONC and CMS Final Regulatory 
documents which can be found at CMS: gpo.gov/fdsys/pkg/FR-2015-10-16/pdf/2015-25595.pdf, and ONC: 
gpo.gov/fdsys/pkg/FR-2015-10-16/pdf/2015-25597.pdf.  
 Electronic Health Record Incentive Payment Program - Public Health Reporting Measures and Standards 
For Eligible Professionals (EPs), Eligible Hospitals (EHs), Critical Access Hospitals (CAHs) 
2014 Edition, Certified Electronic Health Record Technology (CEHRT) and 2015 Edition CEHRT 
Stage/Year  Modified Stage 2 MU (2015-2017) Stage 3 MU (2018, optional 2017) 
ONC Regulation/ 
Certification Edition 
 
2014 CEHRT 2015 CEHRT 
MU Objective  
Public Health Registry Reporting 
Public Health and Clinical Data Registry 
Reporting 
MU Eligible Entities 
(Numbers specify 
the minimum number of 
measures to meet) 
 
(EPs-Eligible 
Professionals; EHs- 
Eligible Hospitals; 
CAHs-Critical Access 
Hospitals) 
EPs in Stage 1, 2015: 1 
EPs in Stage 2, 2015: 2 
EPs in 2016 or 2017: 2 
EHs, CAHs in Stage 1, 2015: 2 
EHs, CAHs in Stage 2, 2015: 3 
EHs, CAHs in 2016 or 2017: 3 
EPs: 2  
EHs: 4 
CAHs: 4 
Measure Name 
Provider Type 
Availability 
ONC-Adopted Standard (2014 CEHRT) ONC-Adopted Standard (2015 CEHRT) 
Immunization Registry 
Reporting  
EP, EH, CAH 
Measure 1 
HL7 2.5.1: Implementation Guide for 
Immunization Messaging, Release 1.4 
Measure 1 
HL7 Version 2.5.1: Implementation Guide for 
Immunization Messaging, Release 1.5 (October 
2014) and Addendum (July 2015) 
Syndromic Surveillance 
Reporting  
Modified Stage 2:  
EP, EH, CAH 
Stage 3 MU: EP 
(Urgent Care Setting 
ONLY), EH, CAH 
Measure 2 
HL7 2.5.1 PHIN Messaging Guide for Syndromic 
Surveillance: Emergency Department and Urgent 
Care Data, Release 1.1 (August 2012) 
Measure 2 
HL7 2.5.1 PHIN Messaging Guide for Syndromic 
Surveillance: Emergency Department, Urgent 
Care, Ambulatory Care and Inpatient Settings, 
Release 2.0 
Specialized Registry 
Reporting 
EP, EH, CAH 
(Cancer Registry 
Reporting only for 
EPs) 
Measure 3 
No standard mandated for Specialized Registry 
Reporting except for Cancer Case Reporting, as a 
specialized registry, from EPs to State Cancer 
Registry 
 
Implementation Guide for Ambulatory Healthcare 
Provider Reporting to Central Cancer Registries, 
HL7 Clinical Document Architecture (CDA), 
(August 2012) 
 
National Health Care Surveys (NHCS) Reporting 
to CDC/NCHS also available. 
Not included in Stage 3 MU 
 
See Measure 4 - Public Health Registry Reporting 
and Measure 5 - Clinical Data Registry Reporting 
Electronic Case 
Reporting 
EP, EH, CAH 
Not included in Modified Stage 2. See Measure 3 - 
Specialized Registry Reporting. 
Measure 3 
Per guidelines in the ONC 2015 Edition 
Certification Final Rule 
 
Not available in 2017 for optional Stage 3 
requirements. 
Electronic Reportable 
Laboratory Results 
Reporting 
EH, CAH only 
Measure 4 
HL7 Version 2.5.1 Implementation Guide: 
Electronic Laboratory Reporting to Public Health, 
Release 1 (US Realm), with Errata and 
Clarifications   
Measure 6 
HL7 2.5.1 Implementation Guide: Electronic 
Laboratory Reporting to Public Health, Release 1 
(US Realm), with Errata and Clarifications 
Public Health Registry 
Reporting 
EP, EH, CAH 
Not included in Modified Stage 2. See Measure 3-
Specialized Registry Reporting. 
Measure 4  
Starting in 2018, only standard based 
transmissions will be accepted based on the 
standards listed below.  
Cancer case reporting from EPs to State 
Cancer Registry-HL7 CDA® Release 2 
Implementation Guide: Reporting to Public Health 
Cancer Registries from Ambulatory Healthcare 
Providers, Release 1; DSTU Release 1.1, (U.S. 
Realm) (EPs Only) 
Antimicrobial use and resistance reporting to 
NHSN-HL7 Implementation Guide for CDA® 
Release 2 –Level 3: Healthcare Associated 
Infection Reports, Release 1, U.S. Realm (August 
2013) (Eligible Hospitals/CAHs only) 
CDC/NCHS Health care surveys-HL7 
Implementation Guide for CDA ® Release 2: 
National Health Care Surveys (NHCS), Release 
1—US Realm, Draft Standard for Trial Use 
(December 2014)  
Clinical Data Registry 
Reporting  
EP, EH, CAH 
Not included in Modified Stage 2. See Measure 3-
Specialized Registry Reporting. 
Measure 5 
No standard included at this time. 
